Growth Metrics

Novartis Ag (NVS) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $80.5 billion.

  • Novartis Ag's Non-Current Assets rose 1095.5% to $80.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $80.5 billion, marking a year-over-year increase of 1095.5%. This contributed to the annual value of $80.5 billion for FY2025, which is 1095.5% up from last year.
  • According to the latest figures from Q4 2025, Novartis Ag's Non-Current Assets is $80.5 billion, which was up 1095.5% from $79.1 billion recorded in Q3 2025.
  • In the past 5 years, Novartis Ag's Non-Current Assets ranged from a high of $100.2 billion in Q2 2021 and a low of $67.0 billion during Q3 2023
  • Its 5-year average for Non-Current Assets is $80.4 billion, with a median of $79.6 billion in 2023.
  • In the last 5 years, Novartis Ag's Non-Current Assets tumbled by 1775.61% in 2023 and then surged by 1095.5% in 2025.
  • Novartis Ag's Non-Current Assets (Quarter) stood at $86.1 billion in 2021, then dropped by 6.43% to $80.5 billion in 2022, then decreased by 13.76% to $69.5 billion in 2023, then grew by 4.43% to $72.5 billion in 2024, then rose by 10.96% to $80.5 billion in 2025.
  • Its Non-Current Assets was $80.5 billion in Q4 2025, compared to $79.1 billion in Q3 2025 and $78.5 billion in Q2 2025.